CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
76.51
-1.74 (-2.22%)
Sep 22, 2026, 12:48 PM EDT - Market open
CG Oncology Employees
CG Oncology had 142 employees as of December 31, 2025. The number of employees increased by 29 or 25.66% compared to the previous year.
Employees
142
Change (1Y)
29
Growth (1Y)
25.66%
Revenue / Employee
$43,859
Profits / Employee
-$1,580,106
Market Cap
6.78B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 142 | 29 | 25.66% |
| Dec 31, 2024 | 113 | 52 | 85.25% |
| Dec 31, 2023 | 61 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ionis Pharmaceuticals | 1,480 |
| Travere Therapeutics | 497 |
| Mirum Pharmaceuticals | 433 |
| Rhythm Pharmaceuticals | 414 |
| CRISPR Therapeutics AG | 393 |
| Immunovant | 315 |
| Scholar Rock Holding | 289 |
| Spyre Therapeutics | 125 |
CGON News
- 7 days ago - CG Oncology Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 13 days ago - CG Oncology Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 20 days ago - CG Oncology to Present at Upcoming Investor Conferences in September - GlobeNewsWire
- 6 weeks ago - CG Oncology price target raised to $85 from $82 at Truist - TheFly
- 6 weeks ago - CG Oncology price target lowered to $79 from $81 at RBC Capital - TheFly
- 6 weeks ago - CG Oncology reports Q2 EPS (90c), consensus (64c) - TheFly
- 6 weeks ago - CG Oncology Earnings release: Q2 2026 - Filings
- 6 weeks ago - CG Oncology Quarterly report: Q2 2026 - Filings